Trial intelligence / Profile preview

Sinolvir vs Eutebrol in Alzheimer's Disease

NCT07417670Phase 4Completed

Sponsor
Carnot Laboratorios
Start
Oct 2024
Primary completion
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Carnot Laboratorios. Started Oct 2024; status: completed.

02

Drugs

memantine
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT07417670.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07417670.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call